Sources | Names Used |
---|---|
CTRPv2 | triazolothiadiazine |
PharmacoGx | triazolothiadiazine |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | RP11-1212A22.4 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0007 |
mRNA | RPL17-C18orf32 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0007 |
mRNA | EHD1 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.0007 |
mRNA | MRPL30 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.0007 |
mRNA | TXNRD3NB | CTRPv2 | pan-cancer | AAC | 0.1 | 0.0007 |
mRNA | ACOT4 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0007 |
mRNA | AP4M1 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.0007 |
mRNA | COCH | CTRPv2 | pan-cancer | AAC | 0.1 | 0.0007 |
mRNA | ECSIT | CTRPv2 | pan-cancer | AAC | 0.1 | 0.0007 |
mRNA | NAGK | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0007 |